Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pavel S. Vydryn"'
Autor:
Vladimir P. Ostrikov, Evgenij G. Karapuzov, Anton V. Nikolskii, Alexey E. Krivenko, Maxim V. Borychev, Dmitriy G. Lebedev, Dmitriy Georgievich Korenkov, Oleg O. Burlaka, Pavel S. Vydryn, Svetlana N. Kalinina, Anton Leonidovich Pavlov
Publikováno v:
Urologicheskie vedomosti. 9:21-28
The article presents the experience of treating patients with urolithiasis in the urological clinic of the Aleksandrovskaya hospital. Due to the improvement of technologies, the number of minimally invasive surgeries such as contact ureterolithotrips
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90fc0e0a4532ac8273cc9a7ae1ad6f25
https://doi.org/10.17816/uroved9321-28
https://doi.org/10.17816/uroved9321-28
Autor:
Mikhail S. Aleksandrov, Mikhail V. Mosharev, Oleg O. Burlaka, Saidzhon A. Madzhidov, Svetlana N. Kalinina, Vladimir N. Fesenko, Pavel S. Vydryn
Publikováno v:
Urologicheskie vedomosti. 9:5-10
The article presents the results of surgical treatment of 36 men aged 18 to 35 years with testicular torsion who were treated at the urological clinic of the Alexandrovskaya Hospital from 2012 to 2017. Indications for surgical treatment were pains in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fca964eb71982e3b33736afa35fd8b4
https://doi.org/10.17816/uroved915-10
https://doi.org/10.17816/uroved915-10
Publikováno v:
Urologicheskie vedomosti. 8:26-33
The efficacy and safety of alpha-1-adrenergic blocker alfuprost MP (alfuzosin) at a dose of 10 mg once a day and a fifth-type phosphodiesterase inhibitor viatile (sildenafil) 50 mg once a day in the combined treatment of 75 patients with benign prost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91b52ac91f01d2ae5c7d0dec8af531fb
https://doi.org/10.17816/uroved8126-33
https://doi.org/10.17816/uroved8126-33